ACO/Pharma Commercial Data Analytics Service Models
1 like850 views
Nintai Partners specializes in pharmaceutical data and informatics, offering unique, partner-driven solutions to tackle the evolving challenges in the industry. They utilize a proprietary six-step evaluation process to enhance data governance and leverage integrated data platforms, emphasizing the importance of flexibility and productivity in achieving long-term growth. The document outlines specific case studies demonstrating their strategic approaches to developing effective data governance structures and integrating diverse data sources.
ACO/Pharma Commercial Data Analytics Service Models
- 1. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. September 6th, 2013 Optimal Commercial Data and Analytics Service Models: An Overview
- 2. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Our Expertise Pharmaceutical Data and Informatics Nintai Partners’ leadership has nearly a quarter century of experience working with pharmaceutical data and informatics. Working with everything from traditional IMS sales data, regulatory CDISC, evidence-based medicine data, and ACO-performance metrics, Nintai Partners provides the most comprehensive knowledge in the marketplace. Deep Understanding of Changes in Pharmaceuticals It isn’t just the breadth and depth of data changing the pharmaceutical world. These data sets are part of a tremendous change in the industry, ranging from drug discovery/development outsourcing, a transition from traditional sales to account-based selling models, and the increasing role of specialty drugs in pharmaceutical companies. portfolios. Putting It All Together Nintai Partners presents a truly innovative approach to creating executable solutions. No engagement is the same and we pride ourselves on unique, partner-driven solutions. We are not afraid to discuss finding and best practices from outside the industry, as well as providing unvarnished recommendations to our partners.
- 3. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Data Services Solution: Core Strategic Drivers No industry has survived by continually cutting their way to survival. The ultimate long term health of the industry will be driven by sustainable and profitable growth. To achieve this, continued increases in productivity need to occur with R&D in order to drive the IRR. New relationships will need to be created – with incentives for both cost savings and corporate growth. These relationships will require more flexible and integrated business models. The industry has never been a leader in the use of informatics, technology, and integrated data platforms. The increasing digitization of data at all levels (EDC, EMRs, eCTD) is going to fundamentally change the way we make decisions.
- 4. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Data Services Solution: Nintai Partners’ Evaluation Process Strategic Need Step 1 What is the strategic need of the data infrastructure? Data Sources Step 2 What currently makes up data source inventory? Data Ownership Step 3 Who currently owns/sponsors each data asset? Data Update/ Validation Step 4 How are these data sources updated and validated? Data Access/ Rights Step 5 Who has access to data and at what authority ? Data Regulatory Needs Step 6 What regulatory requirements are required for data? Nintai Partners utilizes a proprietary six (6) step process to help assess our partners in their data governance structure. This process assures key constituents that the business processes and current assets are maximized.
- 5. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Data Services Solution: Nintai Partners Methodology As an example of Nintai Partners’ proprietary process, illustrated below is an example of how we might approach Phase I (Strategic Need). Data Governance Board Sales Sales Ops Marketing IT/IS Finance Regulatory Clinical Corporate Strategy & Key Objectives What do we want to achieve from a new data informatics strategy and organization? Business Questions Answered What questions need to be answered by the proposed strategy, governance, & structure? Proposed Governance & Data Model What is the best structure and model to answer required questions and meet key objectives? Business Improvement What changes in business processes can drive greater results and improve outcomes? Performance Review & Actions What tools can be utilized to measure performance versus goals and create executable change?
- 6. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Data Services Solution: Example of New Data Requirements Key Tools in ACO Performance Measurement Specialty Pharmacy Data Emphasis on Lx Data Patient Adherence Pharmacy Performance Operations Performance Clinical Metrics Economic Measures Evidence Based Medicine Emphasis on EBM Collaborative Research Doctor Dashboards Doctor Impact Labeling Research Meta Analysis Guideline Consortiums New Data Sets/Tools Prescription Data Emphasis on Rx Data Pharma Market Benchmarking Forecasting Pricing & Market Access Sales Force Performance Existing Data Sets/Tools Sales Data Emphasis on Sales Data Hospital Dispensed Non-Reimbursed OTC (As Applicable) Price Deviation VAT Status
- 7. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Data Services Solution: Case Studies of Nintai Partners’ Work Case 1: Strategic Shift to Specialty Pharmacy (SP) Portfolio Working with a team from McKinsey, Nintai Partners developed a targeted data governance structure which met with key findings. For example, the ability to create a fully integrated message to specialty physicians about efficacy was roughly 6 times more powerful than promoting a new MoA. This meant data MUST be fully integrated internally through a stringent data governance process and included several outside data sources to demonstrate EBM performance. Enterprise Data Warehouse Internal Data Physician prescription data Anonymous patient-level data Payer data CDSC ETMS Pre-Clinical (e.g. Dosing Safety) Phase IV Data External Data Research Meta Analysis Patient Adherence Pharmacy Performance Clinical Metrics EHR Blinded Data Guideline Measures CMS Guidelines Targeted Specialist Campaigns ACO Performance Payer Formulary Reimbursement
- 8. CONFIDENTIAL Copyright 2014 Nintai Partners All Rights Reserved. Permission Required Before Duplication. Case 2: Developing Model Data Governance Model for TBG Integration Early last year, a partner asked Nintai Partners to evaluate the best data governance model to integrate a traditionally independent therapeutic business group (TBG) structure. Utilizing an integrated, multi-department approach Nintai Partners created working groups under a Data Governance Board to review and come up with dynamic solutions addressing specific concerns. Data Services Solution: Case Studies of Nintai Partners Work Political/ Regulatory Impacts Reporting/ Insights Impact Business Process Impact Financial Impact Vendor Impacts Identification of Key Questions, Issues, and Responsibilities Identification of Working Group Solutions Roll Up Report to Data Governance Board and TBGs for Feedback